WU Ke-gui
WU Ke-gui publishes mostly in Cardiology and Cardiovascular Medicine, Pharmacology and Radiology, Nuclear Medicine and Imaging, on topics such as Inflammatory mediators and NSAID effects, Eicosanoids and Hypertension Pharmacology and Cardiac Imaging and Diagnostics.
- World rank
- #7,060,902 of 7,710,434 ranked researchers
- Rank in China
- #937,666 of 978,568
- Works
- 20
- Citations
- 5
- Citations per work
- 0.3
What does WU Ke-gui research?
WU Ke-gui's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1048.9%
- Health Sciences944.7%
- Medicine944.7%
- Life Sciences16.4%
- 1Cardiology and Cardiovascular Medicine13% of their works
- 2Pharmacology11% of their works
- 3Radiology, Nuclear Medicine and Imaging8% of their works
- 4Biochemistry6% of their works
- 5Surgery6% of their works
- 6Endocrinology, Diabetes and Metabolism6% of their works
Research topics
- Inflammatory mediators and NSAID effects
- Eicosanoids and Hypertension Pharmacology
- Cardiac Imaging and Diagnostics
- Atherosclerosis and Cardiovascular Diseases
- Cardiovascular Health and Disease Prevention
- Coronary Interventions and Diagnostics
- Garlic and Onion Studies
- Cancer-related molecular mechanisms research
Which keywords describe WU Ke-gui's research?
The keywords of their largest research topics: Inflammation, Cancer, Hypertension, Atherosclerosis, Cyclooxygenase-2 Inhibitors, Prostaglandins, Arachidonic Acid and Cardiac Imaging.
- RNA Regulation
- Garlic
- Oxidized LDL
- Immune Response
- Coronary Stents
- Epoxyeicosatrienoic Acids
- Cardiac Imaging
- Prostaglandins
- Atherosclerosis
- Cancer
- Inflammation
- Hypertension
- Cyclooxygenase-2 Inhibitors
- Arachidonic Acid
- Coronary Artery Disease
- Arterial Stiffness
- Endothelial Dysfunction
- Myocardial Revascularization
- Bioactive Compounds
- Long Noncoding RNAs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Inflammation93 topics
- Cancer52 topics
- Hypertension52 topics
- Atherosclerosis42 topics
- Cyclooxygenase-2 Inhibitors41 topic
- Prostaglandins41 topic
- Arachidonic Acid31 topic
- Cardiac Imaging31 topic
- Coronary Artery Disease31 topic
- Epoxyeicosatrienoic Acids31 topic
- Arterial Stiffness21 topic
- Coronary Stents21 topic
- Endothelial Dysfunction21 topic
- Immune Response21 topic
- Myocardial Revascularization21 topic
- Oxidized LDL21 topic
- Bioactive Compounds11 topic
- Garlic11 topic
- Long Noncoding RNAs11 topic
- RNA Regulation11 topic
Where does WU Ke-gui work?
WU Ke-gui's main affiliation in the publication record is Fujian Medical University, China.
How many publications and citations does WU Ke-gui have?
OpenAlex counts 20 works and 5 citations for WU Ke-gui, an h-index of 2, ranking #7,060,902 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about WU Ke-gui. Posts are plain text and can be reported.